Latest autoimmune diseases Stories
Multinational, Multidisciplinary Expert Panel Reveals Survey Findings, Asks Patients to Take Pledge as Part of RA: Join the Fight, an AbbVie Global Initiative MADRID, June 11, 2013 /PRNewswire/ -- RA: Join the Fight today presented at a launch event in Madrid the findings from the largest global rheumatoid arthritis (RA) patient survey, which included 10,171 patients across 42 countries. Findings show that while a majority of RA patients (74 percent) say they know a great deal or a...
BEVERLY HILLS, Calif., June 11, 2013 /PRNewswire/ -- Skin Clinical Labs (www.skinclinicalsamples.com) has developed a proprietary topical skin cream that improves micro-circulation and increases oxygenation to help combat various skin conditions including those associated with diabetes, psoriasis and eczema. Skin Clinical has been shown to improve skin thickness, elasticity and overall structure in Phase I and Phase II scientific studies. (Photo:...
Neurological Wellness Center physicians report the alleviation of depression is a predictable outcome of perispinal Enbrel treatment for traumatic brain injury. There is now substantial and accumulating basic science and clinical evidence linking neuro-inflammation with severe depression. (PRWEB) June 07, 2013 In a landmark study published in the Journal Neuropsychopharmacology, Susana G. Torres-Platas analyzed the brains of suicide victims and concludes: "The presence of...
Lee Rannals for redOrbit.com – Your Universe Online Northwestern Medicine researchers say they have discovered a big breakthrough that could help people suffering from multiple sclerosis (MS). The researchers completed the first phase of a clinical trial for the first treatment to reset the immune system of MS patients. They found that the patients showed the therapy was safe and dramatically reduced their immune systems' reactivity to myelin by 50 to 75 percent. In MS, the immune...
Raises Thousands to Support Science and Service for NYC Lupus Community NEW YORK, June 5, 2013 /PRNewswire/ -- The S.L.E. Lupus Foundation's Young Leaders Committee brought together lupus advocates, friends, family members, and coworkers for the highly successful ninth annual "Night for the Fight." With more than 250 guests, New York's young professionals raised more this year than ever to help achieve the Foundation's mission to support novel research and patient services, while...
Awards Will Support Efforts of Tomorrow's Lupus Thought Leaders to Solve the Cruel Mystery of this Unpredictable and Devastating Disease WASHINGTON, June 3, 2013 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, the only national force dedicated to solving the cruel mystery of lupus, announced recipients of five new summer fellowships and the Foundation's first-ever Career Development Award. The Foundation presents these awards to foster interest in a career in lupus...
Efficacy Advantages of TNF-Alpha Inhibitors Will Likely Constrain Uptake of Emerging Therapies, According to a New Report from Decision Resources BURLINGTON, Mass., June 3, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that based on clinical data and the opinions of interviewed thought leaders, AbbVie/Eisai's Humira has the strongest clinical profile among key marketed products that...
HAYWARD, Calif., May 31, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, announced today that Paul F. Truex, President and Chief Executive Officer, and Dr. Colin Hislop, Senior Vice President and Chief Medical Officer, will present a corporate update at the 2013 Annual Jefferies Global Healthcare Conference. Anthera will present on at 1:30PM ET, June 6(th)...
WASHINGTON, May 30, 2013 /PRNewswire-USNewswire/ -- Mark J. Shlomchik, M.D., Ph.D., the new incoming Chair of Immunology at the University of Pittsburgh, has been selected as the first recipient of the Lupus Insight Prize. The first-of-a-kind award provides $200,000 for use in innovative research on lupus, an unpredictable and sometimes fatal autoimmune disease that affects an estimated 1.5 million Americans. (Logo: http://photos.prnewswire.com/prnh/20121113/DC11393LOGO ) The...
Although Rheumatologists Indicate There is an Unmet Need for New RA Drug Therapies, Most Patients Do Not Want to Switch from Their Current Medication, According to a New Report from BioTrends Research Group EXTON, Penn., May 29, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that rheumatoid arthritis patients are moderately to highly satisfied with the drugs, biologic and...
